DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research
SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National…
First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial
FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng…
NFCR Takes Steps to Address Cancer Community Needs During Coronavirus Pandemic
FOR IMMEDIATE RELEASE: April 14, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center…
NFCR-Backed Technology Receives FDA’s Assent for Lymphoma Clinical Trials
FOR IMMEDIATE RELEASE: March 12, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A drug and drug delivery candidate technology, research into which has been…
Michael Hall Named 2020 Sjöberg Prize Recipient
Michael N. Hall, Ph.D., the National Foundation for Cancer Research’s (NFCR) 2017 Szent-Györgyi Prize for Progress in Cancer Research winner, and David Sabatini, M.D., Ph.D., were named winners of the 2020 Sjöberg Prize “for their discovery of the target of…
2020 Szent-Gyorgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product Origin
FOR IMMEDIATE RELEASE: February 13, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) announced today that Susan Band…
NFCR Funded Translational Cancer Research Project Receives Virginia Catalyst Grant
FOR IMMEDIATE RELEASE: December 23, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A translational research project supported by the National Foundation for Cancer Research…
National Foundation for Cancer Research Conducts Salisbury Award Competition
FOR IMMEDIATE RELEASE: November 19, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Winner and Runners-Up Named, Salisbury Family Honored ROCKVILLE, MD – The National Foundation for Cancer Research…
NFCR Fellow Susan Band Horwitz Named Giant of Cancer Care
FOR IMMEDIATE RELEASE: June 3, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Management E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Becomes the Fifth National Foundation for Cancer Research Scientist to Receive the Honor ROCKVILLE,…
NFCR Fellow Susan Band Horwitz Receives Canada Gairdner Award
FOR IMMEDIATE RELEASE: April 2, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Canada’s Most Prominent Scientific Prize Honors World’s Biomedical Research Elite ROCKVILLE, MD – Susan…
NFCR at the 2019 American Association for Cancer Research Annual Meeting
FOR IMMEDIATE RELEASE: March 28, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Profile Includes Distinguished Public Service Award for Daniel Von Hoff ROCKVILLE, MD – The…